Publication | Open Access

Concurrent RB1 and TP53 Alterations Define a Subset of EGFR-Mutant Lung Cancers at risk for Histologic Transformation and Inferior Clinical Outcomes

Tumor BiologyMedicinePathologyTp53 Alterations DefineBronchial NeoplasmCancer GenomicsInferior Clinical OutcomesTumor SuppressorConcurrent Rb1Cancer GeneticsOncologyCell BiologyLung CancerCancer Research